Free Trial

Avidity Biosciences (RNA) Short Interest Ratio & Short Volume

Avidity Biosciences logo
$28.10 -1.67 (-5.61%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$28.02 -0.08 (-0.28%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avidity Biosciences Short Interest Data

Avidity Biosciences (RNA) has a short interest of 16.13 million shares, representing 14.04% of the float (the number of shares available for trading by the public). This marks a -4.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.9, indicating that it would take 11.9 days of the average trading volume of 1.36 million shares to cover all short positions.

Current Short Interest
16,130,000 shares
Previous Short Interest
16,950,000 shares
Change Vs. Previous Month
-4.84%
Dollar Volume Sold Short
$501.80 million
Short Interest Ratio
11.9 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
120,212,000 shares
Short Percent of Float
14.04%
Today's Trading Volume
2,256,859 shares
Average Trading Volume
1,359,621 shares
Today's Volume Vs. Average
166%
Short Selling Avidity Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Avidity Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RNA Short Interest Over Time

RNA Days to Cover Over Time

RNA Percentage of Float Shorted Over Time

Remove Ads

Avidity Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202516,130,000 shares $501.80 million -4.8%14.0%11.9 $31.11
2/28/202516,950,000 shares $519.35 million +2.9%14.7%12.6 $30.64
2/15/202516,480,000 shares $532.47 million +10.2%14.3%12.7 $32.31
1/31/202514,950,000 shares $492.30 million -2.9%N/A11.2 $32.93
1/15/202515,390,000 shares $428.92 million -1.9%N/A12.7 $27.87
12/31/202415,680,000 shares $455.97 million +1.3%N/A13.9 $29.08
12/15/202415,480,000 shares $502.95 million +3.6%N/A13.3 $32.49
11/30/202414,940,000 shares $642.87 million +2.9%N/A11.9 $43.03
11/15/202414,520,000 shares $612.45 million -1.0%N/A11.8 $42.18
10/31/202414,660,000 shares $619.53 million -1.5%N/A11.5 $42.26
10/15/202414,880,000 shares $694.90 million +0.7%N/A11.2 $46.70
9/30/202414,770,000 shares $678.39 million +23.3%N/A10.3 $45.93
9/15/202411,980,000 shares $499.69 million +10.8%N/A7.9 $41.71
8/31/202410,810,000 shares $475.64 million -16.3%N/A6.6 $44.00
8/15/202412,920,000 shares $587.73 million -0.2%N/A7.8 $45.49
7/31/202412,950,000 shares $590.26 million +0.3%N/A8.2 $45.58
7/15/202412,910,000 shares $588.95 million +19.2%N/A8.5 $45.62
6/30/202410,830,000 shares $442.41 million -3.9%N/A7.6 $40.85
6/15/202411,270,000 shares $446.74 million +4.2%N/A8.4 $39.64
5/31/202410,820,000 shares $290.63 million -4.3%N/A10 $26.86
5/15/202411,310,000 shares $333.76 million -0.7%N/A9.3 $29.51
4/30/202411,390,000 shares $274.84 million +6.9%N/A10 $24.13
4/15/202410,660,000 shares $254.88 million +6.8%N/A9 $23.91
3/31/20249,980,000 shares $254.69 million +15.8%N/A8.2 $25.52
3/15/20248,620,000 shares $210.50 million +10.9%N/A7.3 $24.42
2/29/20247,770,000 shares $142.19 million +0.5%N/A6.5 $18.30
2/15/20247,730,000 shares $104.59 million +1.2%N/A5.4 $13.53
1/31/20247,640,000 shares $93.44 million +4.1%N/A5.4 $12.23
1/15/20247,340,000 shares $83.31 million -25.3%N/A5.5 $11.35
12/31/20239,830,000 shares $88.96 million -8.0%N/A7.4 $9.05
12/15/202310,680,000 shares $92.38 million -3.2%N/A8.5 $8.65
11/30/202311,030,000 shares $86.14 million +1.5%N/A9 $7.81
11/15/202310,870,000 shares $67.72 million -6.3%N/A13.7 $6.23
10/31/202311,600,000 shares $59.74 million +0.3%N/A14.7 $5.15
10/15/202311,570,000 shares $71.50 million -25.3%N/A14.5 $6.18
9/30/202315,490,000 shares $98.83 million -7.4%N/A20.3 $6.38
9/15/202316,720,000 shares $117.21 million +2.1%N/A21.3 $7.01
8/31/202316,380,000 shares $123.83 million +2.0%N/A18.2 $7.56
8/15/202316,060,000 shares $139.40 million +2.8%N/A17.9 $8.68
7/31/202315,620,000 shares $148.55 million -2.7%N/A15.7 $9.51
Urgent Bitcoin alert for RIGHT NOW (Ad)

Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”

So please… click here to watch now.
7/15/202316,050,000 shares $173.82 million +2.2%N/A13.4 $10.83
6/30/202315,710,000 shares $174.22 million +11.4%N/A12 $11.09
6/15/202314,100,000 shares $175.97 million +5.2%N/A9.7 $12.48
5/31/202313,400,000 shares $142.31 million +4.4%N/A10.1 $10.62
5/15/202312,840,000 shares $144.45 million +29.3%N/A9.5 $11.25
4/30/20239,930,000 shares $123.13 million -12.4%N/A7.6 $12.40
4/15/202311,330,000 shares $169.72 million +3.9%N/A10.6 $14.98
3/31/202310,910,000 shares $167.47 million +25.6%N/A10.5 $15.35
3/15/20238,690,000 shares $184.05 million +4.6%N/A9.1 $21.18
2/28/20238,310,000 shares $196.95 million +5.5%N/A4.2 $23.70
2/15/20237,880,000 shares $194.64 million +5.1%N/A4.1 $24.70
1/31/20237,500,000 shares $177.75 million -4.7%N/A3.9 $23.70
1/15/20237,870,000 shares $178.26 million -5.0%N/A4.1 $22.65
12/30/20228,280,000 shares $183.73 million +27.2%N/A4.5 $22.19
12/15/20226,510,000 shares $118.16 million -7.3%N/A3.6 $18.15
11/30/20227,020,000 shares $81.71 million -0.1%N/A11.6 $11.64
11/15/20227,030,000 shares $100.53 million +26.7%N/A13.2 $14.30
10/31/20225,550,000 shares $79.25 million +12.6%N/A11.8 $14.28
10/15/20224,930,000 shares $80.90 million +7.4%N/A11.1 $16.41
9/30/20224,590,000 shares $74.95 million -13.4%N/A11.8 $16.33
9/15/20225,300,000 shares $112.36 million +0.8%N/A16.3 $21.20
8/31/20225,260,000 shares $103.20 million -5.6%N/A15.1 $19.62
8/15/20225,570,000 shares $123.71 million -4.5%N/A15.5 $22.21
7/31/20225,830,000 shares $94.97 million -1.2%N/A15.8 $16.29
7/15/20225,900,000 shares $103.43 million +4.1%N/A16.6 $17.53
6/30/20225,670,000 shares $82.39 million +15.0%N/A16.4 $14.53
6/15/20224,930,000 shares $59.31 million +4.9%N/A15.2 $12.03
5/31/20224,700,000 shares $65.47 million +9.3%N/A19.1 $13.93
5/15/20224,300,000 shares $55.69 million +4.6%N/A17.4 $12.95
4/30/20224,110,000 shares $58.77 million +2.8%N/A16.7 $14.30
4/15/20224,000,000 shares $72.88 million -0.3%N/A15.9 $18.22
3/31/20224,010,000 shares $74.06 million +1.3%N/A14.9 $18.47
3/15/20223,960,000 shares $63.44 million +2.3%N/A14.8 $16.02
2/28/20223,870,000 shares $65.64 million +1.8%N/A14 $16.96
2/15/20223,800,000 shares $63.65 million +5.0%N/A13.2 $16.75
1/31/20223,620,000 shares $60.16 million -4.0%N/A14.4 $16.62
1/15/20223,770,000 shares $67.22 million -4.6%N/A16 $17.83
12/31/20213,950,000 shares $93.89 million -7.3%N/A17.9 $23.77
12/15/20214,260,000 shares $103.60 million -9.4%N/A19.1 $24.32
11/30/20214,700,000 shares $104.95 million -3.3%N/A17.6 $22.33
11/15/20214,860,000 shares $119.99 million -8.7%N/A14.9 $24.69
10/29/20215,320,000 shares $119.70 million +1.3%N/A16.4 $22.50
10/15/20215,250,000 shares $112.98 million -6.9%N/A14.4 $21.52
9/30/20215,640,000 shares $138.91 million +3.9%N/A15.3 $24.63
9/15/20215,430,000 shares $124.24 million -16.7%N/A13.7 $22.88
8/31/20216,520,000 shares $148.92 million +3.7%N/A18.4 $22.84
8/13/20216,290,000 shares $122.72 million +3.6%N/A24.1 $19.51
7/30/20216,070,000 shares $117.21 million +0.2%N/A23.5 $19.31
7/15/20216,060,000 shares $135.74 million -1.1%19.0%27.8 $22.40
6/30/20216,130,000 shares $151.47 million -4.2%19.2%26.8 $24.71
Urgent Bitcoin alert for RIGHT NOW (Ad)

Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”

So please… click here to watch now.
6/15/20216,400,000 shares $168.38 million -2.4%20.1%28.3 $26.31
5/28/20216,560,000 shares $155.73 million -0.5%20.6%22.9 $23.74
5/14/20216,590,000 shares $129.30 million +1.2%20.7%20.3 $19.62
4/30/20216,510,000 shares $158.84 million +2.2%20.5%17.3 $24.40
4/15/20216,370,000 shares $135.62 million +9.6%20.1%16.4 $21.29
3/31/20215,810,000 shares $117.83 million +30.6%18.3%15.3 $20.28
3/15/20214,450,000 shares $114.10 million +21.9%14.0%11.7 $25.64
2/26/20213,650,000 shares $92.75 million +14.4%11.5%11.8 $25.41
2/12/20213,190,000 shares $70.91 million +8.5%10.1%11.8 $22.23
1/29/20212,940,000 shares $67.56 million -7.3%9.3%14.3 $22.98
1/15/20213,170,000 shares $84.58 million No Change10.0%16.1 $26.68

RNA Short Interest - Frequently Asked Questions

What is Avidity Biosciences' current short interest?

Short interest is the volume of Avidity Biosciences shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 16,130,000 shares of RNA short. 14.04% of Avidity Biosciences' shares are currently sold short. Learn More on Avidity Biosciences' current short interest.

What is a good short interest ratio for Avidity Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNA shares currently have a short interest ratio of 12.0. Learn More on Avidity Biosciences's short interest ratio.

Which institutional investors are shorting Avidity Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avidity Biosciences: Torno Capital LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Boothbay Fund Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Cinctive Capital Management LP, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Avidity Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.04% of Avidity Biosciences' floating shares are currently sold short.

Is Avidity Biosciences' short interest increasing or decreasing?

Avidity Biosciences saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 16,130,000 shares, a decrease of 4.8% from the previous total of 16,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Avidity Biosciences' short interest compare to its competitors?

14.04% of Avidity Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avidity Biosciences: Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.48%), Dr. Reddy's Laboratories Limited (1.97%), Moderna, Inc. (13.72%), Viatris Inc. (3.91%), Ascendis Pharma A/S (12.03%), Qiagen (1.72%), Roivant Sciences Ltd. (11.87%), Lantheus Holdings, Inc. (9.73%), BridgeBio Pharma, Inc. (15.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Avidity Biosciences stock?

Short selling RNA is an investing strategy that aims to generate trading profit from Avidity Biosciences as its price is falling. RNA shares are trading down $1.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avidity Biosciences?

A short squeeze for Avidity Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNA, which in turn drives the price of the stock up even further.

How often is Avidity Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNA, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:RNA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners